secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2022-03-08T23:59:59+00:00
Accession:  0001104659-22-031154
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Ivan Delevic resigns from MedTech Acquisition Board; Thierry Thaure joins Audit Committee
--------------------------------------------------------------------------------

- Ivan Delevic resigned from MedTech Acquisition Corp.'s Board of Directors and all positions effective March 4, 2022, not due to any disagreement.
- Thierry Thaure appointed to the Audit Committee, joining Karim Karti and Manuel Aguero, all independent under Nasdaq rules.
- The Board of Directors expressed gratitude for Delevic's service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922031154/0001104659-22-031154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465922031154/tm228615d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-031154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer